Work

Abstract 6173: Preclinical studies of BB-1712: A B7H3-targeting eribulin-containing ADC with the potential to overcome resistance to DNA topoisomerase I inhibitor-containing ADCs

Year: 2025
Type: conference-abstract
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W4409629495
Cites:
Cited by:
Related to: 10